Mortality benefits and overdiagnosis estimates for women attending breast screening
A partir d'une revue de la littérature, ce rapport d'un comité d'experts indépendants analyse la controverse concernant les bénéfices et les risques associés au dépistage organisé triennal du cancer du sein au Royaume-Uni chez les femmes âgées de 50 à 70 ans
The recent well-publicised Marmot review (Independent UK Panel on Breast Cancer Screening, 2012; Marmot et al, 2013) provides much-needed insight into the estimated harms and benefits of breast screening but, as it is an intention-to-treat analysis, sets out its main findings in terms of women invited to screening. Such an analysis does not need to adjust for either non-compliance or loss to follow-up, and is useful for assessing the effect of the intervention on society, but it is not designed to portray the likely impact of screening on an individual.
British Journal of Cancer , commentaire en libre accès, 2012